levofolinic acid medac 50 micromol solution for inj/inf
medac gesellschaft fur klinische spezialpraparate - levofolinic acid sodium hydroxide - solution for inj/inf - 50 micromol
leflunomide medac
medac gesellschaft für klinische spezialpräparate mbh - leflunomide - arthritis, rheumatoid - selective immunosuppressants - leflunomide is indicated for the treatment of adult patients with:active rheumatoid arthritis as a 'disease-modifying antirheumatic drug' (dmard).recent or concurrent treatment with hepatotoxic or haematotoxic dmards (e.g. methotrexate) may result in an increased risk of serious adverse reactions, therefore, the initiation of leflunomide treatment has to be carefully considered regarding these benefit / risk aspects.moreover, switching from leflunomide to another dmard without following the washout procedure may also increase the risk of serious adverse reactions even for a long time after the switching.
urokinase medac 10,000 iu, powder for solution for infusion
medac gesellschaft fur klinische spezialpraparate mbh - urokinase - powder for solution for infusion - 10,000 international unit(s) - enzymes; urokinase
urokinase medac 50,000 iu, powder for solution for infusion
medac gesellschaft fur klinische spezialpraparate mbh - urokinase - powder for solution for infusion - 50,000 international unit(s) - enzymes; urokinase
urokinase medac 100,000 iu, powder for solution for infusion
medac gesellschaft fur klinische spezialpraparate mbh - urokinase - powder for solution for infusion - 100,000 international unit(s) - enzymes; urokinase
urokinase medac 250,000 iu powder for solution for infusion
medac gesellschaft fur klinische spezialpraparate mbh - urokinase - powder for solution for infusion - 250,000 international unit(s) - enzymes; urokinase
urokinase medac 500,000 iu, powder for solution for infusion
medac gesellschaft fur klinische spezialpraparate mbh - urokinase - powder for solution for infusion - 500,000 international unit(s) - enzymes; urokinase
mitomycin medac 20 mg powder and solvent for intravesical solution
medac gesellschaft fur klinische spezialpraparate mbh - mitomycin - pdr+solv/soln/intravesical use - 20 milligram(s) - other cytotoxic antibiotics; mitomycin
bendamustine medac 25 milligram pdr/conc/soln for infus
medac gesellschaft fur klinische spezialpraparate mbh - bendamustine hydrochloride - pdr/conc/soln for infus - 25 milligram - alkylating agents
bendamustine medac 100 milligram pdr/conc/soln for infus
medac gesellschaft fur klinische spezialpraparate mbh - bendamustine hydrochloride - pdr/conc/soln for infus - 100 milligram - alkylating agents